Huntington Ingalls Industries (HII) reports $3.1B Q2 revenue, backlog at $56.9B, with enhanced free cash flow guidance.

Segment operating income2 in the second quarter of 2025 was $172 million and segment operating margin2 was 5.6%, compared to $203 million and 6.8%, respectively, in the second quarter of 2024. The ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.

Thanks to Abacus AI for sponsoring this video. Prime Day sales are here and there are hundreds of keyboards to choose from!